The EGM resolved, in accordance with the Board of Directors’ proposal, to adopt an incentive program for the CEO of the company by a directed issue of warrants with the right to subscribe for new shares in the company. The company shall issue a maximum of 100,000 warrants that give the right to subscribe for 100,000 new shares. The right to subscribe for the warrants shall, with deviation from the shareholders’ preferential right, accrue to the CEO. Subscription of shares by exercise of subscription warrants shall take place during the period from and including 1 December 2026 up to and including 2 January 2027. The subscription price per share shall amount to 160 percent of SEK 32.86, corresponding to the volume-weighted average value according to Nasdaq Stockholm’s official price list for shares in the company during the period of ten trading days preceding the general meeting. In the event that all warrants are exercised, the number of shares will increase by 100,000, which corresponds to a dilution of a maximum of approximately 0.5 percent of the shares and votes based on the company’s current number of shares.
For more information, please visit www.sleepcycle.com or contact:
+46 70 939 5327
About Sleep Cycle
With millions of daily active users and over two billion nights analyzed in more than 150 countries, Sleep Cycle is the leading sleep tracking application and one of the most widely used solutions worldwide to improve sleep health. Sleep Cycle’s mission is to improve global health by empowering people to sleep better. Since its launch in 2009, Sleep Cycle has helped millions of people understand their sleep habits and improve their sleep. The mobile application helps users fall asleep more easily, tracks and analyses sleep during the night, wakes the user in a light sleep phase and provides insight into how sleep quality is best improved. Sleep Cycle is one of the world’s most comprehensive sources for statistics on sleep and contributes to research and reporting on sleep worldwide. Sleep Cycle is listed on Nasdaq Stockholm under the ticker SLEEP. The head office is located in Gothenburg, Sweden.